Blueprint Medicines Corp

NASDAQ:BPMC   11:28:00 AM EDT
93.18
-0.56 (-0.60%)
Earnings Announcements

Blueprint Medicines Reports Q1 Loss Per Share Of $1.72

Published: 04/29/2021 11:09 GMT
Blueprint Medicines Corp (BPMC) - Blueprint Medicines Reports First Quarter 2021 Financial Results.
Q1 Loss per Share $1.72.
Q1 Revenue $21.6 Million.
Q1 Earnings per Share View $-1.87, Revenue View $17.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $22.08 Million
Adjusted EPS is expected to be -$1.84

Next Quarter Revenue Guidance is expected to be $47.06 Million
Next Quarter EPS Guidance is expected to be -$1.59

More details on our Analysts Page.